Real World Evidence Clinical Utility Study of KidneyIntelX
NCT04802395
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this study is to assess the impact of the KidneyIntelX assay utilized as part of the current standard of care on the management of patients seen in the primary care physician's office at Mount Sinai.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Chronic Kidney Diseases
- Diabetic Kidney Disease
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 23 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Renalytix AI, Inc.
- Last updated on ClinicalTrials.gov
- August 13, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
New York · 1
- Mount Sinai Health System · New York, NY
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.